Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference

References

• JensenRStovnerLJEpidemiology and comorbidity of headacheLancet Neurol20087435436118339350
   PubMed Web of Science ®Google Scholar
• StovnerLHagenKJensenRThe global burden of headache: a documentation of headache prevalence and disability worldwideCephalalgia200727319321017381554
   PubMed Web of Science ®Google Scholar
• The International Classification of Headache Disorders2nd editionCephalalgia200424Suppl 1916014979299
   PubMed Web of Science ®Google Scholar
• BenseñorIMLotufoPAGoulartACMenezesPRScazufcaMThe prevalence of headache among elderly in a low-income area of São Paulo, BrazilCephalalgia200828432933318294252
   PubMed Web of Science ®Google Scholar
• ZwartJDybGHolmenTLStovnerLJSandTThe prevalence of migraine and tension-type headaches among adolescents in Norway. The Nord-Trøndelag Health Study (Head-HUNT-Youth), a large population-based epidemiological studyCephalalgia200424537337915096226
   PubMed Web of Science ®Google Scholar
• ObermannMYoonMDommesPPrevalence of trigeminal autonomic symptoms in migraine: a population-based studyCephalalgia200727650450917428298
   PubMed Web of Science ®Google Scholar
• BarbantiPFabbriniGPesareMVanacoreNCerboRUnilateral cranial autonomic symptoms in migraineCephalalgia200222425625912100086
   PubMed Web of Science ®Google Scholar
• KurthTSchürksMLogroscinoGGazianoJMBuringJEMigraine, vascular risk, and cardiovascular events in women: prospective cohort studyBMJ2008337a63618687721
   PubMed Web of Science ®Google Scholar
• KelmanLThe aura: a tertiary care study of 952 migraine patientsCephalalgia200424972873415315528
   PubMed Web of Science ®Google Scholar
• LiptonRBScherAIKolodnerKMigraine in the United States: epidemiology and patterns of health care useNeurology200258688589411914403
   PubMed Web of Science ®Google Scholar
• MattssonPLundbergPOCharacteristics and prevalence of transient visual disturbances indicative of migraine visual auraCephalalgia199919547948410403062
   PubMed Web of Science ®Google Scholar
• ReuterURioMSDDienerHMigraines with and without aura and their response to preventive therapy with topiramateCephalalgia200993 Epub ahead of print
   Google Scholar
• GiffinNJRuggieroLLiptonRBPremonitory symptoms in migraine: an electronic diary studyNeurology200360693594012654956
   PubMed Web of Science ®Google Scholar
• MacGregorEABrandesJEikermannAMigraine prevalence and treatment patterns: the global Migraine and Zolmitriptan Evaluation surveyHeadache2003431192612864754
   PubMed Web of Science ®Google Scholar
• CevoliSD’AmicoDMartellettiPUnderdiagnosis and undertreatment of migraine in Italy: a survey of patients attending for the first time 10 headache centresCephalalgia20091020 Epub ahead of print
   Google Scholar
• Members of the task forceEversSAfraJFreseAEFNS guideline on the drug treatment of migraine – report of an EFNS task forceEur J Neurol200613656057216796580
   PubMed Web of Science ®Google Scholar
• SilbersteinSDPractice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of NeurologyNeurology200055675476210993991
   PubMed Web of Science ®Google Scholar
• MayTWRambeckBJürgensUSerum concentrations of topiramate in patients with epilepsy: influence of dose, age, and comedicationTher Drug Monit200224336637412021627
   PubMed Web of Science ®Google Scholar
• DienerHTfelt-HansenPDahlöfCTopiramate in migraine prophylaxis–results from a placebo-controlled trial with propranolol as an active controlJ Neurol2004251894395015316798
   PubMed Web of Science ®Google Scholar
• ZonaCCiottiMTAvoliMTopiramate attenuates voltage-gated sodium currents in rat cerebellar granule cellsNeurosci Lett199723131231269300637
   PubMed Web of Science ®Google Scholar
• ZhangXVelumianAAJonesOTCarlenPLModulation of high-voltage-activated calcium channels in dentate granule cells by topiramateEpilepsia200041Suppl 1S52S6010768302
   PubMed Web of Science ®Google Scholar
• QianJNoebelsJLTopiramate alters excitatory synaptic transmission in mouse hippocampusEpilepsy Res200355322523312972176
   PubMed Web of Science ®Google Scholar
• WhiteHSBrownSDWoodheadJHSkeenGAWolfHHTopiramate modulates GABA-evoked currents in murine cortical neurons by a non-benzodiazepine mechanismEpilepsia200041Suppl 1S17S2010768294
   PubMed Web of Science ®Google Scholar
• ShankRPDooseDRStreeterAJBialerMPlasma and whole blood pharmacokinetics of topiramate: the role of carbonic anhydraseEpilepsy Res2005632–310311215715969
   PubMed Web of Science ®Google Scholar
• EversSTreatment of migraine with prophylactic drugsExpert Opin Pharmacother20089152565257318803445
   PubMed Web of Science ®Google Scholar
• RabkinRStablesDPLevinNWSuzmanMMThe prophylactic value of propranolol in angina pectorisAm J Cardiol19661833703834958813
   PubMed Web of Science ®Google Scholar
• Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial painHeadache Classification Committee of the International Headache SocietyCephalalgia19888Suppl 7196
   Google Scholar
• LiptonRBBigalMEDiamondMMigraine prevalence, disease burden, and the need for preventive therapyNeurology200768534334917261680
   PubMed Web of Science ®Google Scholar
• MorilloLEAlarconFAranagaNClinical characteristics and patterns of medication use of migraneurs in Latin America from 12 cities in 6 countriesHeadache200545211812615705116
   PubMed Web of Science ®Google Scholar
• LucasCChaffautCArtazMLantéri-MinetMFRAMIG 2000: medical and therapeutic management of migraine in FranceCephalalgia200525426727915773824
   PubMed Web of Science ®Google Scholar
• Von SeggernRLMannixLKAdelmanJUEfficacy of topiramate in migraine prophylaxis: a retrospective chart analysisHeadache200242880480912390645
   PubMed Web of Science ®Google Scholar
• YoungWBHopkinsMMShechterALSilbersteinSDTopiramate: a case series study in migraine prophylaxisCephalalgia200222865966312383061
   PubMed Web of Science ®Google Scholar
• StoreyJRCalderCSHartDEPotterDLTopiramate in migraine prevention: a double-blind, placebo-controlled studyHeadache2001411096897511903524
   PubMed Web of Science ®Google Scholar
• EdwardsKRPotterDLWuSKaminMHulihanJTopiramate in the preventive treatment of episodic migraine: a combined analysis from pilot, double-blind, placebo-controlled trialsCNS Spectr20038642843212858132
   PubMed Web of Science ®Google Scholar
• SilbersteinSDNetoWSchmittJJacobsDGroupMIGRSTopiramate in migraine prevention: results of a large controlled trialArch Neurol200461449049515096395
   PubMedGoogle Scholar
• BrandesJLSaperJRDiamondMTopiramate for migraine prevention: a randomized controlled trialJAMA2004291896597314982912
   PubMed Web of Science ®Google Scholar
• BussoneGDienerHPfeilJSchwalenSTopiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trialsInt J Clin Pract200559896196816033621
   PubMed Web of Science ®Google Scholar
• VerspeeltJDe LochtPAmeryWKPost-marketing cohort study comparing the safety and efficacy of flunarizine and propranolol in the prophylaxis of migraineCephalalgia19961653283368869768
   PubMed Web of Science ®Google Scholar
• LindeKRossnagelKPropranolol for migraine prophylaxisCochrane Database Syst Rev20042CD00322515106196
   PubMedGoogle Scholar
• RapoportAMauskopADienerHSchwalenSPfeilJLong-term migraine prevention with topiramate: open-label extension of pivotal trialsHeadache20064671151116016866719
   PubMed Web of Science ®Google Scholar
• DienerHAgostiRAllaisGCessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trialLancet Neurol20076121054106217988947
   PubMed Web of Science ®Google Scholar
• KosinskiMBaylissMSBjornerJBA six-item short-form survey for measuring headache impact: the HIT-6Qual Life Res200312896397414651415
   PubMed Web of Science ®Google Scholar
• LiptonRBStewartWFSawyerJEdmeadsJGClinical utility of an instrument assessing migraine disability: the Migraine Disability Assessment (MIDAS) questionnaireHeadache200141985486111703471
   PubMed Web of Science ®Google Scholar
• WareJKosinskiMKellerSDA 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validityMed Care19963432202338628042
   PubMed Web of Science ®Google Scholar
• CastilloJMunozPGuiteraVPascualJKaplan Award 1998. Epidemiology of chronic daily headache in the general populationHeadache199939319019615613213
   PubMed Web of Science ®Google Scholar
• ScherAIStewartWFLibermanJLiptonRBPrevalence of frequent headache in a population sampleHeadache199838749750615613165
   PubMed Web of Science ®Google Scholar
• SilbersteinSDLiptonRBSliwinskiMClassification of daily and near-daily headaches: field trial of revised IHS criteriaNeurology19964748718758857711
   PubMed Web of Science ®Google Scholar
• KatsaravaZSchneeweissSKurthTIncidence and predictors for chronicity of headache in patients with episodic migraineNeurology200462578879015007133
   PubMed Web of Science ®Google Scholar
• OlesenJBousserMDienerHNew appendix criteria open for a broader concept of chronic migraineCephalalgia200626674274616686915
   PubMed Web of Science ®Google Scholar
• MeiDFerraroDZelanoGTopiramate and triptans revert chronic migraine with medication overuse to episodic migraineClin Neuropharmacol200629526927516960472
   PubMed Web of Science ®Google Scholar
• SilvestriniMBartoliniMCocciaMTopiramate in the treatment of chronic migraineCephalalgia200323882082414510929
   PubMed Web of Science ®Google Scholar
• BartoliniMSilvestriniMTaffiREfficacy of topiramate and valproate in chronic migraineClin Neuropharmacol200528627727916340383
   PubMed Web of Science ®Google Scholar
• LimmrothVBiondiDPfeilJSchwalenSTopiramate in patients with episodic migraine: reducing the risk for chronic forms of headacheHeadache2007471132117355489
   PubMed Web of Science ®Google Scholar
• SilbersteinSDLiptonRBDodickDWEfficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trialHeadache200747217018017300356
   PubMed Web of Science ®Google Scholar
• DienerHBussoneGOeneJCVTopiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled studyCephalalgia200727781482317441971
   PubMed Web of Science ®Google Scholar
• DienerHDodickDWGoadsbyPJUtility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuseCephalalgia200929101021102719735529
   PubMed Web of Science ®Google Scholar
• SilbersteinSLiptonRDodickDTopiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measuresHeadache20094981153116219719543
   PubMed Web of Science ®Google Scholar
• SilbersteinSDControl of topiramate-induced paresthesias with supplemental potassiumHeadache20024218512005283
   PubMed Web of Science ®Google Scholar
• Lyseng-WilliamsonKAYangLPHTopiramate: a review of its use in the treatment of epilepsyDrugs200767152231225617927286
   PubMed Web of Science ®Google Scholar
• ZiadEKRahiACHamdanSAMikatiMAAge, dose, and environmental temperature are risk factors for topiramate-related hyperthermiaNeurology20056571139114016217081
   PubMed Web of Science ®Google Scholar
• LáinezMJAFreitagFGPfeilJTime course of adverse events most commonly associated with topiramate for migraine preventionEur J Neurol200714890090617662012
   PubMed Web of Science ®Google Scholar
• TaylorFRWeight change associated with the use of migraine-preventive medicationsClin Ther20083061069108018640463
   PubMed Web of Science ®Google Scholar
• MorrowJRussellAGuthrieEMalformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy RegisterJ Neurol Neurosurg Psychiatr200677219319816157661
   PubMed Web of Science ®Google Scholar
• OrnoyAZviNArnonJThe outcome of pregnancy following topiramate treatment: a study on 52 pregnanciesReprod Toxicol200825338838918424066
   PubMed Web of Science ®Google Scholar
• HuntSRussellASmithsonWHTopiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy RegisterNeurology200871427227618645165
   PubMed Web of Science ®Google Scholar
• OhmanIVitolsSLuefGSöderfeldtBTomsonTTopiramate kinetics during delivery, lactation, and in the neonate: preliminary observationsEpilepsia200243101157116012366729
   PubMed Web of Science ®Google Scholar
• PalmieriCCangerRTeratogenic potential of the newer antiepileptic drugs: what is known and how should this influence prescribing?CNS Drugs2002161175576412383031
   PubMed Web of Science ®Google Scholar
• EyalSYagenBSobolEThe activity of antiepileptic drugs as histone deacetylase inhibitorsEpilepsia200445773774415230695
   PubMed Web of Science ®Google Scholar
• GurvichNBermanMGWittnerBSAssociation of valproate-induced teratogenesis with histone deacetylase inhibition in vivoFASEB J20051991166116815901671
   PubMed Web of Science ®Google Scholar
• LewisDWYonkerMWinnerPSowellMThe treatment of pediatric migrainePediatr Ann200534644846016018227
   PubMed Web of Science ®Google Scholar
• StewartWFLinetMSCelentanoDDVan NattaMZieglerDAge- and sex-specific incidence rates of migraine with and without visual auraAm J Epidemiol199113410111111201746521
   PubMed Web of Science ®Google Scholar
• StewartWFLiptonRBCelentanoDDReedMLPrevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factorsJAMA1992267164691727198
   PubMed Web of Science ®Google Scholar
• Abu-ArefehIRussellGPrevalence of headache and migraine in schoolchildrenBMJ199430969577657697950559
   PubMed Web of Science ®Google Scholar
• HersheyADWhat is the impact, prevalence, disability, and quality of life of pediatric headache?Curr Pain Headache Rep20059534134416157063
   PubMedGoogle Scholar
• PakalnisAPediatric migraine: new diagnostic strategies and treatment optionsExpert Rev Neurother20066329129616533133
   PubMedGoogle Scholar
• LewisDWinnerPSaperJRandomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of agePediatrics2009123392493419255022
   PubMed Web of Science ®Google Scholar
• LakshmiCVSSinghiPMalhiPRayMTopiramate in the prophylaxis of pediatric migraine: a double-blind placebo-controlled trialJ Child Neurol200722782983517715274
   PubMed Web of Science ®Google Scholar
• WinnerPPearlmanEMLinderSLTopiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trialHeadache200545101304131216324162
   PubMed Web of Science ®Google Scholar
• FerraroDTrapaniGDTopiramate in the prevention of pediatric migraine: literature reviewJ Headache Pain20089314715018385933
   PubMed Web of Science ®Google Scholar
• DienerHCMatias-GuiuJHartungEEfficacy and tolerability in migraine prophylaxis of flunarizine in reduced doses: a comparison with propranolol 160 mg dailyCephalalgia200222320922112047461
   PubMed Web of Science ®Google Scholar
• DienerHCHartungEChrubasikJA comparative study of oral acetylsalicyclic acid and metoprolol for the prophylactic treatment of migraine. A randomized, controlled, double-blind, parallel group phase III studyCephalalgia200121212012811422094
   PubMed Web of Science ®Google Scholar
• DienerHCFöhMIaccarinoCCyclandelate in the prophylaxis of migraine: a randomized, parallel, double-blind study in comparison with placebo and propranolol. The Study groupCephalalgia19961664414478902255
   PubMed Web of Science ®Google Scholar
• DodickDWFreitagFBanksJTopiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineursClin Ther200931354255919393844
   PubMed Web of Science ®Google Scholar
• WheelerSDCarrazanaEJTopiramate-treated cluster headacheNeurology199953123423610408573
   PubMed Web of Science ®Google Scholar
• FörderreutherSMayerMStraubeATreatment of cluster headache with topiramate: effects and side-effects in five patientsCephalalgia200222318618912047455
   PubMed Web of Science ®Google Scholar
• LáinezMJAPascualJPascualAMTopiramate in the prophylactic treatment of cluster headacheHeadache200343778478912890134
   PubMed Web of Science ®Google Scholar
• MathewNTDynamic optimization of chronic migraine treatment: current and future optionsNeurology2009725 SupplS14S2019188563
   PubMed Web of Science ®Google Scholar
• PascualJRivasMTLeiraRTesting the combination beta-blocker plus topiramate in refractory migraineActa Neurol Scand20071152818317212609
   PubMed Web of Science ®Google Scholar
• KeskinboraKAydinliIA double-blind randomized controlled trial of topiramate and amitriptyline either alone or in combination for the prevention of migraineClin Neurol Neurosurg20081101097998418620801
   PubMed Web of Science ®Google Scholar